147 related articles for article (PubMed ID: 12938213)
1. OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses.
Ishii N; Ndhlovu LC; Murata K; Sato T; Kamanaka M; Sugamura K
Eur J Immunol; 2003 Sep; 33(9):2372-81. PubMed ID: 12938213
[TBL] [Abstract][Full Text] [Related]
2. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function.
Mendel I; Shevach EM
Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055
[TBL] [Abstract][Full Text] [Related]
3. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
[TBL] [Abstract][Full Text] [Related]
4. Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma.
Hoshino A; Tanaka Y; Akiba H; Asakura Y; Mita Y; Sakurai T; Takaoka A; Nakaike S; Ishii N; Sugamura K; Yagita H; Okumura K
Eur J Immunol; 2003 Apr; 33(4):861-9. PubMed ID: 12672051
[TBL] [Abstract][Full Text] [Related]
5. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
[TBL] [Abstract][Full Text] [Related]
6. Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis.
Akiba H; Miyahira Y; Atsuta M; Takeda K; Nohara C; Futagawa T; Matsuda H; Aoki T; Yagita H; Okumura K
J Exp Med; 2000 Jan; 191(2):375-80. PubMed ID: 10637281
[TBL] [Abstract][Full Text] [Related]
7. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice.
Sato T; Ishii N; Murata K; Kikuchi K; Nakagawa S; Ndhlovu LC; Sugamura K
Eur J Immunol; 2002 Nov; 32(11):3326-35. PubMed ID: 12555678
[TBL] [Abstract][Full Text] [Related]
8. Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.
Murata K; Nose M; Ndhlovu LC; Sato T; Sugamura K; Ishii N
J Immunol; 2002 Oct; 169(8):4628-36. PubMed ID: 12370402
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis.
Totsuka T; Kanai T; Uraushihara K; Iiyama R; Yamazaki M; Akiba H; Yagita H; Okumura K; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G595-603. PubMed ID: 12631559
[TBL] [Abstract][Full Text] [Related]
10. Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions.
Pakala SV; Bansal-Pakala P; Halteman BS; Croft M
Eur J Immunol; 2004 Nov; 34(11):3039-46. PubMed ID: 15368274
[TBL] [Abstract][Full Text] [Related]
11. Non-MHC-linked Th2 cell development induced by soluble protein administration predicts susceptibility to Leishmania major infection.
Guéry JC; Galbiati F; Smiroldo S; Adorini L
J Immunol; 1997 Sep; 159(5):2147-53. PubMed ID: 9278301
[TBL] [Abstract][Full Text] [Related]
12. OX40 ligand regulates splenic CD8⁻ dendritic cell-induced Th2 responses in vivo.
Kamachi F; Harada N; Usui Y; Sakanishi T; Ishii N; Okumura K; Miyake S; Akiba H
Biochem Biophys Res Commun; 2014 Feb; 444(2):235-40. PubMed ID: 24462862
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation.
Arestides RS; He H; Westlake RM; Chen AI; Sharpe AH; Perkins DL; Finn PW
Eur J Immunol; 2002 Oct; 32(10):2874-80. PubMed ID: 12355440
[TBL] [Abstract][Full Text] [Related]
14. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
[TBL] [Abstract][Full Text] [Related]
15. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
[TBL] [Abstract][Full Text] [Related]
16. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.
van Wanrooij EJ; van Puijvelde GH; de Vos P; Yagita H; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):204-10. PubMed ID: 17068285
[TBL] [Abstract][Full Text] [Related]
17. The role of OX40 ligand interactions in the development of the Th2 response to the gastrointestinal nematode parasite Heligmosomoides polygyrus.
Ekkens MJ; Liu Z; Liu Q; Whitmire J; Xiao S; Foster A; Pesce J; VanNoy J; Sharpe AH; Urban JF; Gause WC
J Immunol; 2003 Jan; 170(1):384-93. PubMed ID: 12496423
[TBL] [Abstract][Full Text] [Related]
18. Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo.
Kaneko H; Hori T; Yanagita S; Kadowaki N; Uchiyama T
Exp Hematol; 2005 Mar; 33(3):336-43. PubMed ID: 15730857
[TBL] [Abstract][Full Text] [Related]
19. The crystal structure of the costimulatory OX40-OX40L complex.
Compaan DM; Hymowitz SG
Structure; 2006 Aug; 14(8):1321-30. PubMed ID: 16905106
[TBL] [Abstract][Full Text] [Related]
20. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
